FR2355505A1 - Nouvel agent adjuvant immunitaire - Google Patents

Nouvel agent adjuvant immunitaire

Info

Publication number
FR2355505A1
FR2355505A1 FR7619236A FR7619236A FR2355505A1 FR 2355505 A1 FR2355505 A1 FR 2355505A1 FR 7619236 A FR7619236 A FR 7619236A FR 7619236 A FR7619236 A FR 7619236A FR 2355505 A1 FR2355505 A1 FR 2355505A1
Authority
FR
France
Prior art keywords
acetamido
deoxy
alanyl
glutamine
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7619236A
Other languages
English (en)
Other versions
FR2355505B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7619236A priority Critical patent/FR2355505A1/fr
Publication of FR2355505A1 publication Critical patent/FR2355505A1/fr
Application granted granted Critical
Publication of FR2355505B1 publication Critical patent/FR2355505B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention est relative à un nouvel agent adjuvant immunologique. Cet agent est le 2-(2-acétamido-2-déoxy-3-O-D-glucopyranosyl)-acétyl-L- alanyl-D-isoglutamine de formule :
FR7619236A 1976-06-24 1976-06-24 Nouvel agent adjuvant immunitaire Granted FR2355505A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7619236A FR2355505A1 (fr) 1976-06-24 1976-06-24 Nouvel agent adjuvant immunitaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7619236A FR2355505A1 (fr) 1976-06-24 1976-06-24 Nouvel agent adjuvant immunitaire

Publications (2)

Publication Number Publication Date
FR2355505A1 true FR2355505A1 (fr) 1978-01-20
FR2355505B1 FR2355505B1 (fr) 1979-03-02

Family

ID=9174820

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7619236A Granted FR2355505A1 (fr) 1976-06-24 1976-06-24 Nouvel agent adjuvant immunitaire

Country Status (1)

Country Link
FR (1) FR2355505A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005682A1 (fr) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Dérivés sililés de glucosamine, leur procédé de préparation et médicaments les contenant
EP0006068A2 (fr) * 1978-06-05 1979-12-12 ANVAR Agence Nationale de Valorisation de la Recherche Composés du type muramyl-peptide et médicaments les contenant
EP0050703A2 (fr) * 1978-02-24 1982-05-05 Ciba-Geigy Ag Dérivés du glucose et méthode pour leur préparation
US4574058A (en) * 1978-02-24 1986-03-04 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4652449A (en) * 1982-07-05 1987-03-24 Centre National De La Recherche Scientifique (Cnrs) Encapsulating biological active substances into erythrocytes
GB2458473A (en) * 2008-03-17 2009-09-23 Imuthes Ltd 3'-O-allyl- and 3'-O-carboxymethyl- 2'-aminosaccharide derivatives, & amides thereof with peptides, as adjuvants
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
US4391800A (en) 1979-04-27 1983-07-05 Merck & Co., Inc. Immunologically active peptidyl disaccharides and methods of preparation

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050703A2 (fr) * 1978-02-24 1982-05-05 Ciba-Geigy Ag Dérivés du glucose et méthode pour leur préparation
EP0050703A3 (en) * 1978-02-24 1982-06-02 Ciba-Geigy Ag Glucose derivatives, method for their preparation and their use
US4574058A (en) * 1978-02-24 1986-03-04 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
EP0005682A1 (fr) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Dérivés sililés de glucosamine, leur procédé de préparation et médicaments les contenant
WO1979001088A1 (fr) * 1978-05-18 1979-12-13 Ciba Geigy Ag Nouveaux derives de la glucosamine silylee et leur procede de preparation
EP0006068A2 (fr) * 1978-06-05 1979-12-12 ANVAR Agence Nationale de Valorisation de la Recherche Composés du type muramyl-peptide et médicaments les contenant
EP0006068A3 (en) * 1978-06-05 1980-01-09 Anvar Agence Nationale De Valorisation De La Recherche Compounds of the muramyl-peptide type and medicines containing them
US4652449A (en) * 1982-07-05 1987-03-24 Centre National De La Recherche Scientifique (Cnrs) Encapsulating biological active substances into erythrocytes
US4752586A (en) * 1982-07-05 1988-06-21 Centre National De La Recherche Scientifique Apparatus for encapsulating biological active substances into erythrocytes
GB2458473A (en) * 2008-03-17 2009-09-23 Imuthes Ltd 3'-O-allyl- and 3'-O-carboxymethyl- 2'-aminosaccharide derivatives, & amides thereof with peptides, as adjuvants
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy

Also Published As

Publication number Publication date
FR2355505B1 (fr) 1979-03-02

Similar Documents

Publication Publication Date Title
OA08724A (fr) Treatment of human viral infections by dsRNA combined with viral inhibitors.
FI864125A0 (fi) Heterocykliska foereningar och deras framstaellning samt anvaendning.
IT8050360A0 (it) Sistema portatile su persona per la infusione di insulina
SE8104497L (sv) Kiselkarbidforpolymerer
FR2355505A1 (fr) Nouvel agent adjuvant immunitaire
DK336688A (da) Nucleosider od fremgangsmaade til fremstilling deraf
ES8607020A1 (es) Acidos 1-ciclopropilquinolon-3-carboxilicos
DK208987D0 (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
SE8903003D0 (sv) Novel medical use
ES523521A0 (es) Procedimiento para la preparacion de oxazolidin-2,4-dionas.
GB2019848B (en) 3-(acyloxy or alkoxy) - 9,11 - epoxypregna - 1,3,5(6) - trienes, and their use in the synthesis of 6 -halo corticoids
IT8645710A0 (it) Procedimento e dispositivo per la fabbricazione di mobili per apparecchi frigoriferi.
ES2066753T3 (es) Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.
IT7819138A0 (it) Procedimento per la coltura di microrganismi.
IL52278A (en) -dialkoxymethyl- -formyl(or carbaloxy)- phenyl-propionitriles, their preparation and their use as intermediates in the preparation of trimethoprim and some
FI790359A (fi) Nya 4-(cykloalkyl- eller cykloalkenylsubstituerade)amino alkyl-amino eller alkenylamino-bensoesyror salter och derivat
ES2032407T3 (es) Procedimiento para preparar 1,3-dioxenonas opticamente puras. (reserva del art. 167.2 cpe).
FI883255A0 (fi) Maenniskans papillomavirus, typ 41 dess dna och av dna:et kodade protein.
SU600102A1 (ru) Стекло
IT210224Z2 (it) Cuscino con superficie speculare per l'abbronzatura del viso.
IT1093956B (it) Conduttura per liquidi divisa in due parti,dotata di mezzi per l'accoppiamento fra le due parti della conduttura,specie per uso medicale
DK0459176T3 (da) Oligophosphater med antiviral virkning
JPS5372492A (en) Piezo-electric vibrator
JPS5294791A (en) Manufacture of piezoelectric oscillator unit
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.

Legal Events

Date Code Title Description
ST Notification of lapse